Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2015 May 1;125(5):2179. doi: 10.1172/JCI82091

Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor

Klaus-Dieter Preuss, Michael Pfreundschuh, Martin Weigert, Natalie Fadle, Evi Regitz, Boris Kubuschok
PMCID: PMC4463221  PMID: 25932679

José Carreras Center for Immuno- and Gene Therapy, Internal Medicine I, Saarland University Medical School, Homburg (Saar), Germany.

Original citation: J Clin Invest. 2015;125(1):316–323. doi:10.1172/JCI76802.

Citation for this corrigendum: J Clin Invest. 2015;125(5):2179. doi:10.1172/JCI82091.

Martin Weigert was inadvertently omitted from the author list. The correct author and affiliation lists appear above.

The authors regret the error.

Footnotes

See the related article beginning on page 316.


Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES